{"timestamp": 1771604717.0252476, "value": {"ticker": "RXRX", "company_name": "Recursion Pharmaceuticals, Inc.", "short_name": "Recursion Pharmaceuticals, Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 1834792832, "float_shares": 504102786, "shares_outstanding": 514190251, "short_ratio": 8.17, "short_percent_of_float": 0.3369, "shares_short": 165548707, "shares_short_prior": 165731774, "insider_percent_held": 0.02948, "institution_percent_held": 0.65176004, "total_cash": 659836032, "total_debt": 82374000, "total_revenue": 43689000, "revenue_growth": -0.802, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": -33.27575, "debt_to_equity": 7.868, "current_ratio": 4.604, "book_value": 2.129, "price_to_book": 1.6533115, "operating_cashflow": -441164992, "free_cashflow": -227066496, "price": 3.5199, "52w_high": 12.36, "52w_low": 3.45, "avg_volume": 22290905, "avg_volume_10d": 22908380, "full_time_employees": 800, "audit_risk": 10, "overall_risk": 10}}